US President Trump says Elon Musk will not do anything wrong regarding access to Starlink (SPCX) in Ukraine
Newsquawk Staff ·
- Trump also emphasised the need to protect geniuses like him
What it means
This sits in the recurring tension between private control of strategically critical infrastructure and state foreign policy. Starlink has functioned as de facto military communications backbone for Ukrainian forces, and in prior episodes of this kind the question has been where operational discretion lies: with the service provider, the funding government, or the contracting terms that bind them. Presidential assurances of this sort are political framing rather than contractual commitment; the operative variables have historically been who pays for the service, what the defence department agreements stipulate, and whether access decisions are insulated from any single executive's preference. Episodes where battlefield communications depend on a single commercial supplier have tended to produce pressure toward formalised, government-controlled arrangements rather than reliance on goodwill. The follow-ons worth noting are any shift in how the service is funded or contracted, commentary from defence officials, and whether the remark prefigures a broader negotiation posture on support for Ukraine, since access assurances have in the past been bound up with wider diplomatic bargaining. As a signal, it is directional rather than actionable; the tell is whether rhetoric is followed by changes in contract structure.
- CNBC speculates that Verizon (VZ) would most likely be involved in the context of a partnership with SpaceX (SPCX)
- Ukraine President Zelensky says the Tesla (TSLA)/SpaceX (SPCX) Starlink and Starshield service remains slowed
- US EQUITY OPEN: Breadth poor at the open: Energy leads gains on oil rally, Tech sees slight bounce
- Meta (META) says it will extend the implementation date of updated commercial terms to November 20th (prev. October 30th); extension will allow it to explain the changes to partners and stakeholders
- Abbott (ABT) presents new ESMO data showing 30% absolute improvement in sensitivity with the whole-genome sequencing Oncodetect test in colorectal cancer
Related headlines
- Daily US Equity Opening News: SPCX explores access to 80K US cell sites; OpenAI nears USD 30bln funding at $1.25T valuation2 hours ago
- American Express (AXP) to cut 5% of jobs2 hours ago
- US BROKER MOVES: HESM upgraded at Raymond James; NCLH downgraded at JPM2 hours ago
- Oracle (ORCL) to invest USD 1bln in partner ecosystem over 4 years3 hours ago
- Bristol-Myers Squibb (BMY) says Iza-Bren reduced the risk of progression or death by 59% in Phase 3 breast cancer study; median PFS 8.2 months vs 4.0 months for chemotherapy; cORR 40.5% vs 20.2%; mDOR 6.9 vs 4.2 months4 hours ago
- American Express (AXP) Q3 2026 (USD): EPS 5.42 (exp. 4.50), Revenue 20.1bln (exp. 20.1bln)4 hours ago
- Booz Allen (BAH) Q2 2026 (USD): Adj. EPS 1.76 (exp. 1.48), Revenue 2.80bln (prev. 2.81bln)4 hours ago
- SLB (SLB) Q3 2026 (USD): adj. EPS 0.64 (exp. 0.62), Revenue 9.45bln (exp. 9.27bln)4 hours ago
- Citi (C) has been granted approval by China for its securities unit7 hours ago
- Tesla (TSLA) has decided not to proceed with plans to produce Cybertruck for Australia and New Zealand15 hours ago
- OpenAI trims valuation target to USD 1.25tln after previously pitching a higher price, according to FT17 hours ago
- Newmont (NEM) says production growth is expected to begin in 2027 following previously flagged 2026 trough, adds Q3 gold production was broadly flat sequentially as anticipated17 hours ago
- SpaceX (SPCX) in talks to access 80,000 cell sites for new network17 hours ago
- Google (GOOG) announces general availability of an Anthropic-managed deployment option for Claude models on Google Cloud18 hours ago
- OpenAI is raising up to USD 30bln in funding round at a USD 1.25tln valuation, led by UAE investors, according to CNBC, citing sources; OpenAI is negotiating a commercial deal that would secure more computing capacity from the UAE19 hours ago